GABA fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Gabather AB engages in the research and development of drug candidates for treatment of diseases affecting the central nervous system. It focuses on anti-psychotics, anti-depressants and anxiolytics, analgesics and cognition-enhancing treatments. The company was founded by Bert Roland Kari Junno, Olov Arvid Sterner, Knut Mikael Ingolf Lindstam and Mogens Nielsen on November 3, 2014 and is headquartered in Sodertalje, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
GABA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company